Standout Papers

Trial of Spesolimab for Generalized Pustular Psoriasis 2021 2026 2022 2024181
  1. Trial of Spesolimab for Generalized Pustular Psoriasis (2021)
    H. Bachelez, Siew Eng Choon et al. New England Journal of Medicine

Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Exposure to smoking and greenspace are associated with allergy medicine use – A study of wastewater in 28 cities of China
2025 Standout
Atopic dermatitis
2025 Standout
2 intermediate papers

Works of Siew Eng Choon being referenced

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
2021
Trial of Spesolimab for Generalized Pustular Psoriasis
2021 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Siew Eng Choon 998 675 291 365 50 1.4k
Laurence Le Cleach 792 791 558 531 64 2.0k
H. Bachelez 1160 779 250 97 40 1.4k
Pierre‐Dominique Ghislain 665 604 332 430 36 1.4k
Robert M. Day 1325 831 405 93 31 2.0k
Camille Hua 718 446 165 120 40 1.6k
Masafumi Iijima 402 464 344 783 64 1.6k
Rosaline Chung‐Yee Hui 344 406 428 780 56 1.4k
Angelo Ruggiero 960 855 243 59 98 1.5k
Luca Potestio 729 795 203 59 110 1.3k
Benno Schnyder 472 515 282 1370 39 1.9k

All Works

Loading papers...

Rankless by CCL
2026